WaferGen Bio Beta vs. Total Asset
Considering WaferGen Bio's profitability and operating efficiency indicators, WaferGen Bio systems may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in May. Profitability indicators assess WaferGen Bio's ability to earn profits and add value for shareholders.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Please note, there is a significant difference between WaferGen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if WaferGen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WaferGen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For WaferGen Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of WaferGen Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well WaferGen Bio systems utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between WaferGen Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of WaferGen Bio systems over time as well as its relative position and ranking within its peers.
WaferGen |
WaferGen Bio systems Total Asset vs. Beta Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining WaferGen Bio's current stock value. Our valuation model uses many indicators to compare WaferGen Bio value to that of its competitors to determine the firm's financial worth. WaferGen Bio systems is rated third in beta category among related companies. It is rated below average in total asset category among related companies fabricating about 12,517,582 of Total Asset per Beta. Comparative valuation analysis is a catch-all model that can be used if you cannot value WaferGen Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WaferGen Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WaferGen Bio's earnings, one of the primary drivers of an investment's value.WaferGen Total Asset vs. Beta
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
WaferGen Bio |
| = | 0.91 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
WaferGen Bio |
| = | 11.39 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
WaferGen Total Asset Comparison
WaferGen Bio is currently under evaluation in total asset category among related companies.
Beta Analysis
WaferGen Bio returns are very sensitive to returns on the market. As the market goes up or down, WaferGen Bio is expected to follow.
WaferGen Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in WaferGen Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, WaferGen Bio will eventually generate negative long term returns. The profitability progress is the general direction of WaferGen Bio's change in net profit over the period of time. It can combine multiple indicators of WaferGen Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific.
WaferGen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on WaferGen Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of WaferGen Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the WaferGen Bio's important profitability drivers and their relationship over time.
Use WaferGen Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if WaferGen Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WaferGen Bio will appreciate offsetting losses from the drop in the long position's value.WaferGen Bio Pair Trading
WaferGen Bio systems Pair Trading Analysis
The ability to find closely correlated positions to Gap could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gap when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gap - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gap Inc to buy it.
The correlation of Gap is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gap moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gap Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gap can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your WaferGen Bio position
In addition to having WaferGen Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Top Crypto Assets Thematic Idea Now
Top Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in null. The Top Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Top Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the WaferGen Bio systems information on this page should be used as a complementary analysis to other WaferGen Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in WaferGen Stock
If you are still planning to invest in WaferGen Bio systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the WaferGen Bio's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |